Celltrion (KRX:068270) will participate in a Milan trade convention in October to expand its network of global partners, according to a Tuesday statement.

Through the trade show, the company looks to gain partners in new drug development, supply chain diversification and cost competitiveness, as well as contract development and manufacturing organizations (CDMOs).

The 2026 Convention on Pharmaceutical Ingredients (CPHI) Worldwide will run from Oct. 6 to 8, with more than 60,000 participating industry experts from 2,400 companies and 170 countries.